Stock Exchange & Press Releases 2022

Print Print this release
March 10, 2022

World Sleep 2022 Congress: Bittium Exhibits Home Sleep Apnea Testing Solutions

Press release

Free for publication on March 10, 2022, at 1.00 p.m. (CET +1)

World Sleep 2022 Congress: Bittium Exhibits Home Sleep Apnea Testing Solutions 

Oulu, Finland, March 10, 2022 – Bittium participates in World Sleep 2022 congress in Rome, Italy on March 11–16, 2022. The event is a global congress for sleep medicine and research. Bittium exhibits Bittium Respiro™ - a modern sleep apnea screening device and analysis service solution for service providers, hospitals, clinics, and health centers. It is focused on Home Sleep Apnea Testing (HSAT), and it is intended to record PG level data and analyze typical sleep-related breathing disorders.

Bittium Respiro™ is an end-to-end solution consisting of a measuring device, analysis software, and a service platform that utilizes artificial intelligence to speed up analysis work. The solution pre-analyses the massive amount of measurement data and converts it to a more visual and informative format. This makes it easier and quicker for healthcare personnel to perform further analysis and diagnosis. Bittium MedicalSuite™ provides the same cloud backend system for all Bittium medical products and services and enables fast and location-independent data analysis.

Sleep apnea is a serious medical condition, and if left untreated, it is associated with an array of adverse health consequences, including cardiovascular disease, metabolic disorders, diabetes, cognitive impairment, and depression. The most common type of sleep-disordered breathing is obstructive sleep apnea (OSA).

"Bittium has over 35 years of experience in measuring and monitoring biosignals in the areas of cardiology and neurophysiology. Expanding our expertise to new diagnostic solutions is a natural step forward. We have put considerable efforts into the development of our home sleep apnea testing solution, and as a result, we are proud to exhibit Bittium Respiro™, which is an impressive combination of a measuring device, analysis software, and service platform," says Antti Näykki, Senior Vice President of Bittium Medical Technologies.  

For more information about Bittium Respiro™, please visit or contact our sales at

To register for the event, please visit .

Further information:

Antti Näykki
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507

Main media


Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health, and sports medicine. Net sales in 2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki.